Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Disabled is a bona fide component of the Abl signaling network.

Development (Cambridge, England) | 2010

Abl is an essential regulator of cell migration and morphogenesis in both vertebrates and invertebrates. It has long been speculated that the adaptor protein Disabled (Dab), which is a key regulator of neuronal migration in the vertebrate brain, might be a component of this signaling pathway, but this idea has been controversial. We now demonstrate that null mutations of Drosophila Dab result in phenotypes that mimic Abl mutant phenotypes, both in axon guidance and epithelial morphogenesis. The Dab mutant interacts genetically with mutations in Abl, and with mutations in the Abl accessory factors trio and enabled (ena). Genetic epistasis tests show that Dab functions upstream of Abl and ena, and, consistent with this, we show that Dab is required for the subcellular localization of these two proteins. We therefore infer that Dab is a bona fide component of the core Abl signaling pathway in Drosophila.

Pubmed ID: 20940230 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: Intramural NIH HHS, United States
    Id: Z01 NS003013
  • Agency: NEI NIH HHS, United States
    Id: R01 EY013256
  • Agency: NEI NIH HHS, United States
    Id: R01 EY014597-09
  • Agency: NINDS NIH HHS, United States
    Id: Z01NS003013
  • Agency: NEI NIH HHS, United States
    Id: R01 EY014597
  • Agency: NEI NIH HHS, United States
    Id: R01 EY014597-08
  • Agency: NEI NIH HHS, United States
    Id: EY014597

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.